BRAF mutation correlates with worse local-regional control following radiation therapy in patients with stage III melanoma.

Wolfe, Adam R; Chablani, Priyanka; Siedow, Michael R; Miller, Eric D; Walston, Steve; Kendra, Kari L; Wuthrick, Evan; Williams, Terence M

Wolfe, Adam R; Chablani, Priyanka; Siedow, Michael R; Miller, Eric D; Walston, Steve; Kendra, Kari L; Wuthrick, Evan; Williams, Terence M.

Affiliation

Wolfe AR; Department of Radiation Oncology, The University of Arkansas for Medical Sciences, The Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, USA.
Chablani P; Division of Hematology-Oncology, Department of Internal Medicine, University of Chicago, Chicago, IL, USA.
Siedow MR; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Miller ED; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Walston S; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Kendra KL; Division of Hematology-Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Wuthrick E; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Williams TM; Department of Radiation Oncology, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA, 91010, USA. terwilliams@coh.org.

Radiat Oncol ; 16(1): 181, 2021 Sep 18.

Article in En | MEDLINE | ID: mdl-34537078

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Melanoma / Mutation Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Radiat Oncol Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2021 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google